scPharmaceuticals Inc. Banner Image

scPharmaceuticals Inc.

  • Ticker SCPH
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
 scPharmaceuticals Inc. Logo Image
  • 11-50 Employees
  • Based in Burlington, MA
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary subcutaneous formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients outsideMore of the acute care setting. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.
4.6 / 5.0 (12)

scPharmaceuticals Inc. reports have an aggregate usefulness score of 4.6 based on 12 reviews.

scPharmaceuticals Inc.

Most Recent Annual Report

 scPharmaceuticals Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

 scPharmaceuticals Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!